Clin2
NCT06996704Worth exploringRecruiting

Study of AK0610 in healthy adults

Healthy Volunteer Study

This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
136 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You must be between 18 and 50 years old.
  • Men must weigh at least 50 kg (110 lbs), women at least 45 kg (99 lbs), with a BMI between 18 and 28.
  • You should be in generally good health, with no major medical conditions.
  • If you are able to become pregnant or get someone pregnant, you must use highly effective birth control for one year after receiving the drug.
  • You cannot have taken any prescription, over-the-counter, or herbal medications (except birth control) within 14 days before the study starts.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07432698Not yet recruiting· Phase 1
Testing AK0406 injection safety in healthy volunteers

This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.

Bayswater, Victoria
NCT06947109Not yet recruiting· Phase 1
Study of AK139 in healthy volunteers

This trial tests a new medicine called AK139 in healthy people to see how safe it is and how the body processes it. It is for healthy adults aged 18 to 55.

Hangzhou, Zhejiang
NCT07757659Not yet recruiting· Phase 1
Study of a new drug in healthy adults

This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.

Melbourne
NCT07429006Recruiting· Phase 1
First human trial of AKB-9090 in healthy adults

This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.

Auckland
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07413536Not yet recruiting· Phase 1
Healthy volunteer study of a new injection (EB070) given under the skin

This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.

Hear when a new Healthy Volunteer Study trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.